Joseph Pav

1.1k total citations
17 papers, 903 citations indexed

About

Joseph Pav is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Joseph Pav has authored 17 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Joseph Pav's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Analytical Chemistry and Chromatography (3 papers). Joseph Pav is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Analytical Chemistry and Chromatography (3 papers). Joseph Pav collaborates with scholars based in United States, Japan and Germany. Joseph Pav's co-authors include Susan E. Hattox, James J. Keirns, Michael Lamson, Thomas R. MacGregor, John P. Sabo, Paul Riska, J L Sullivan, Marcus N. Myers, Karin D. Caldwell and J. Calvin Giddings and has published in prestigious journals such as Nature Medicine, Cancer and The Journal of Infectious Diseases.

In The Last Decade

Joseph Pav

16 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Pav United States 12 626 415 178 111 75 17 903
Teresa L. Parsons United States 19 500 0.8× 223 0.5× 249 1.4× 78 0.7× 61 0.8× 39 869
Agnes I. Veldkamp Netherlands 17 697 1.1× 510 1.2× 185 1.0× 118 1.1× 140 1.9× 27 943
Robert L. St. Claire United States 15 308 0.5× 204 0.5× 137 0.8× 28 0.3× 125 1.7× 26 1.1k
P. L. Meenhorst Netherlands 19 682 1.1× 355 0.9× 261 1.5× 115 1.0× 134 1.8× 37 1.1k
Michael Lamson United States 12 579 0.9× 398 1.0× 132 0.7× 114 1.0× 140 1.9× 25 842
Kristel M. L. Crommentuyn Netherlands 16 661 1.1× 334 0.8× 154 0.9× 105 0.9× 246 3.3× 21 864
Laura Dickinson United Kingdom 19 662 1.1× 374 0.9× 163 0.9× 155 1.4× 191 2.5× 68 999
Robin DiFrancesco United States 18 538 0.9× 298 0.7× 137 0.8× 117 1.1× 204 2.7× 53 968
Nicole White United States 16 577 0.9× 319 0.8× 299 1.7× 89 0.8× 149 2.0× 40 885
Katy H. P. Moore United States 16 745 1.2× 393 0.9× 305 1.7× 123 1.1× 120 1.6× 24 1.1k

Countries citing papers authored by Joseph Pav

Since Specialization
Citations

This map shows the geographic impact of Joseph Pav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Pav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Pav more than expected).

Fields of papers citing papers by Joseph Pav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Pav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Pav. The network helps show where Joseph Pav may publish in the future.

Co-authorship network of co-authors of Joseph Pav

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Pav. A scholar is included among the top collaborators of Joseph Pav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Pav. Joseph Pav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Keller, Stephen, Jorge Quiroz, Enaksha Wickremsinhe, et al.. (2021). The Effectiveness of Quality Control Samples in Pharmaceutical Bioanalysis. Bioanalysis. 13(3). 135–145.
2.
Limsakun, Tharin, Victor Dishy, Jeanne Mendell, et al.. (2020). Safety and Pharmacokinetics of DS‐1040 Drug‐Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin. The Journal of Clinical Pharmacology. 60(6). 691–701. 3 indexed citations
3.
4.
Vandell, Alexander G., Satoshi Inoue, Joseph Pav, et al.. (2018). A Phase I, Single‐Ascending‐Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS‐2969b, a Novel GyrB Inhibitor. The Journal of Clinical Pharmacology. 58(12). 1557–1565. 8 indexed citations
5.
Zhou, Jin, Jarema Kochan, Ophelia Yin, et al.. (2017). A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects. Journal of Thrombosis and Haemostasis. 15(5). 961–971. 26 indexed citations
6.
Lamson, Michael, John P. Sabo, Thomas R. MacGregor, et al.. (1999). Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers. Biopharmaceutics & Drug Disposition. 20(6). 285–291. 53 indexed citations
7.
Pav, Joseph, et al.. (1999). HPLC-UV method for the quantitation of nevirapine in biological matrices following solid phase extraction. Journal of Pharmaceutical and Biomedical Analysis. 20(1-2). 91–98. 50 indexed citations
8.
Musoke, Philippa, Laura Guay, Danstan Bagenda, et al.. (1999). A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS. 13(4). 479–486. 166 indexed citations
9.
Riska, Paul, Michael Lamson, Thomas R. MacGregor, et al.. (1999). Disposition and Biotransformation of the Antiretroviral Drug Nevirapine in Humans. Drug Metabolism and Disposition. 27(8). 895–901. 174 indexed citations
10.
Mirochnick, Mark, Terry Fenton, Paul Gagnier, et al.. (1998). Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates. The Journal of Infectious Diseases. 178(2). 368–374. 160 indexed citations
11.
Grob, Peter M., Yunzhen Cao, Elizabeth Muchmore, et al.. (1997). Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase. Nature Medicine. 3(6). 665–670. 28 indexed citations
12.
Cheeseman, Sarah H., Susan E. Hattox, Margaret McLaughlin, et al.. (1993). Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrobial Agents and Chemotherapy. 37(2). 178–182. 91 indexed citations
13.
Kaiko, Robert F., et al.. (1989). Bioavailability of rectal and oral ms contin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(3). 177. 3 indexed citations
14.
15.
Pav, Joseph, et al.. (1981). Separation of reduced disaccharides derived from glycosaminoglycans by high-performance liquid chromatography. Journal of Chromatography A. 212(1). 65–73. 19 indexed citations
16.
Giddings, J. Calvin, Marcus N. Myers, Karin D. Caldwell, & Joseph Pav. (1979). Steric field-flow fractionation as a tool for the size characterization of chromatographic supports. Journal of Chromatography A. 185. 261–271. 64 indexed citations
17.
Milano, M., et al.. (1978). Characterization of the photodiode array detector in liquid chromatography. Journal of Chromatography A. 149. 599–614. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa L. Parsons Breakdown of academic impact, for papers by Agnes I. Veldkamp Breakdown of academic impact, for papers by Robert L. St. Claire Breakdown of academic impact, for papers by P. L. Meenhorst Breakdown of academic impact, for papers by Michael Lamson Breakdown of academic impact, for papers by Kristel M. L. Crommentuyn Breakdown of academic impact, for papers by Laura Dickinson Breakdown of academic impact, for papers by Robin DiFrancesco Breakdown of academic impact, for papers by Nicole White Breakdown of academic impact, for papers by Katy H. P. Moore
Rankless by CCL
2026